AI assistant
Sending…
LEMAITRE VASCULAR INC — Director's Dealing 2019
Aug 8, 2019
31708_dirs_2019-08-08_fdee9291-bcb6-46fd-ad5f-bae4a3135c10.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2019-08-06
Reporting Person: Jasinski Lawrence J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-06 | Common Stock | M | 2500 | $11.43 | Acquired | 10833 | Direct |
| 2019-08-06 | Common Stock | M | 5000 | $14.13 | Acquired | 15833 | Direct |
| 2019-08-06 | Common Stock | S | 5000 | $32 | Disposed | 8333 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-06 | Stock Option (Right to Buy) | $11.43 | M | 2500 | Disposed | 2020-07-23 | Common Stock (2500) | Direct |
| 2019-08-06 | Stock Option (Right to Buy) | $14.13 | M | 5000 | Disposed | 2021-07-25 | Common Stock (5000) | Direct |
Footnotes
F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2: This option is fully vested and exercisable.
More from LEMAITRE VASCULAR INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Apr 14
Annual Report
2026
Apr 14
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3